The Application of T1 Mapping in Real-World
Recruiting
Observational Study
Myocardial Infarction (MI)
Hypertrophic Cardiomyopathy (HCM)
Dilated Cardiomyopathy (DCM)
Arrhythmogenic Cardiomyopathy
Myocarditis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to create a comprehensive real-world spectrum of T1 mapping measurements across different heart conditions. We aim to establish reference values for how heart tissue characteristics vary in various diseases, which will help doctors better interpret these advanced MRI measurements in clinical practice. The main questions it aims to answer are:
What are the n…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adult patients (≥18 years) with clinically diagnosed myocardial diseases based on current international guidelines.
2. Specific disease categories include:
* Cardiomyopathies (HCM, DCM, RCM, ACM)
* Infiltrative disorders (cardiac amyloidosis, Fabry disease)
* Inflam…
Contacts